Edition:
United Kingdom

Concert Pharmaceuticals Q1 Loss Per Share $0.93


Thursday, 2 May 2019 

Concert Pharmaceuticals Inc ::CONCERT PHARMACEUTICALS REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS.Q1 LOSS PER SHARE $0.93.Q1 REVENUE $1.0 MILLION VERSUS $10.5 MILLION.Q1 EARNINGS PER SHARE ESTIMATE $-0.62 -- REFINITIV IBES DATA.Q1 REVENUE ESTIMATE $5.3 MILLION -- REFINITIV IBES DATA.CASH, CASH EQUIVALENTS AND INVESTMENTS AS OF MARCH 31, 2019, TOTALED $153.8 MILLION. 

Company Quote

10.75
-0.18 -1.65%
19 Jul 2019